Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Double-Blind, Controlled, Randomized Study to Evaluate the Safety and Preliminary Efficacy of a Single Dose Intradiscal Injection of BRTX-100 for Patients With Chronic Lumbar Disc Disease (cLDD)

NCT04042844 is registered in ClinicalTrials.gov with BioRestorative Therapies as lead sponsor.

NCT NCT04042844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04042844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Double-Blind, Controlled, Randomized Study to Evaluate the Safety and Preliminary Efficacy of a Single Dose Intradiscal Injection of BRTX-100 for Patients With Chronic Lumbar Disc Disease (cLDD)
Lead sponsor
BioRestorative Therapies
Phase
Phase 2
Overall status
Recruiting
Start date
June 30, 2022
Completion date
December 31, 2027
Enrollment
99 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

lumbar disc disease